Biogen (BIIB) Asset Utilization Ratio (2009 - 2026)
Biogen (BIIB) posted quarterly Asset Utilization Ratio of 0.33 for Q2 2026, down 8.17% year-over-year from 0.35 in Q2 2025, and down 3.43% quarter-over-quarter from 0.34 in Q1 2026.
Biogen (BIIB) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Biogen's Asset Utilization Ratio history runs 18 years deep, the most recent figure standing at 0.33 for Q2 2026.
- In Q2 2026, Asset Utilization Ratio fell 8.17% year-over-year to 0.33; the TTM figure through Jun 2026 stood at 0.33 (down 8.17% YoY), while the FY2025 annual figure was 0.34, down 2.39% from the prior year.
- Asset Utilization Ratio for Q2 2026 stood at 0.33, down from 0.34 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.46 in Q1 2022, with the low at 0.33 in Q2 2026.
- The 5-year median for Asset Utilization Ratio is 0.36 (2023), against an average of 0.37.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio decreased 13.21% in 2023, then advanced 0.36% in 2025.
- Biogen's Asset Utilization Ratio stood at 0.41 in 2022, then declined by 13.21% to 0.36 in 2023, then dropped by 3.94% to 0.34 in 2024, then fell by 1.76% to 0.34 in 2025, then retreated by 3.42% to 0.33 in 2026.
- Business Quant data shows BIIB's Asset Utilization Ratio at 0.33 in Q2 2026, 0.34 in Q1 2026, and 0.34 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 0.64 |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.33 |
| Mar 31, 2026 | 0.34 |
| Dec 31, 2025 | 0.34 |
| Sep 30, 2025 | 0.35 |
| Jun 30, 2025 | 0.35 |
| Mar 31, 2025 | 0.35 |
| Dec 31, 2024 | 0.34 |
| Sep 30, 2024 | 0.35 |
| Jun 30, 2024 | 0.36 |
| Mar 31, 2024 | 0.36 |
| Dec 31, 2023 | 0.36 |
| Sep 30, 2023 | 0.37 |
| Jun 30, 2023 | 0.40 |
| Mar 31, 2023 | 0.41 |
| Dec 31, 2022 | 0.41 |
| Sep 30, 2022 | 0.42 |
| Jun 30, 2022 | 0.44 |
| Mar 31, 2022 | 0.46 |
| Dec 31, 2021 | 0.46 |
| Sep 30, 2021 | 0.46 |